Randomized Comparative Cross Sectional Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Comparative Cross Sectional Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Comparative Cross Sectional Study Today - Breaking & Trending Today

Biosimilar Candidate GP40141 Found Similar to Romiplostim for Idiopathic Thrombocytopenic Purpura

Published: December 1, 2023

The aim of developing GP40141 as a biosimilar is to help reduce the cost of the drug and make treatment more affordable for those with idiopathic thrombocytopenic purpura, according to investigators.

Source: pharmacytimes.com

Related Topics:

Pharmacology ResearchRandomized Comparative Cross Sectional StudyCompletion Date